In patients with periodontal disease or oral cancer, dental membranes and bone graft substitutes are employed for dental bone regeneration treatments. To facilitate cell proliferation, dental membranes are employed in conjunction with dental bone grafts. The rising number of oral health disorders, more product releases, and rising dental health spending are all driving the market for dental membrane and bone transplant alternatives. Geistlich Pharma North America Inc., for example, announced the debut of two new resorbable collagen membranes, Geistlich Bio-Gide Compressed and Geistlich Bio-Gide Shape, in April 2018.
Over the forecast period, rising oral health disorders are expected to fuel market growth.
The global U.S. Dental Membrane and Bone Graft Substitutes Market are growing due to an increase in oral health issues such as cavities and gum disease. An unhealthy diet, tobacco use, excessive alcohol intake, and poor dental hygiene are all factors that contribute to oral health problems. According to the Centers for Disease Control and Prevention's 2019-2020 report, moreover, a quarter (26%) of adults in the United States have untreated dental decay, and nearly half (46%) of all persons 30 and older have indications of gum disease.
During the forecast period, the market is expected to rise due to an increase in product introductions.
The dental membrane and bone graft substitute market in the United States are predicted to rise at a rapid pace during the forecast period, driven by rising demand for effective implants and membranes for dental restoration as a result of rising oral health concerns. Manufacturers are concentrating on producing new and highly efficient implant and restoration products in order to meet rising demand. In February 2019, Zimmer Biomet Holdings, a worldwide healthcare corporation, announced the addition of non-resorbable membranes and sutures to its dental product portfolio.
The Impact of Coronavirus on the Dental Membrane and Bone Graft Substitutes Market in the United States (COVID-19) Pandemic
During the forecast period, the COVID-19 pandemic is likely to stymie the expansion of the dental membrane and bone graft replacements market in the United States. Up until September 23, 2021, about 43 million cases and 0.69 million deaths due to coronavirus (COVID-19) were reported in the United States, according to the World Health Organization's Coronavirus Disease (COVID-19) Weekly Epidemiological Update.
Players to Watch
Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical, Medtronic, and OUSIA are among the major players in the dental membrane and bone graft substitutes market in the United States.
During the forecast period, the market is expected to rise due to an increase in product introductions.
The dental membrane and bone graft substitute market in the United States are predicted to rise at a rapid pace during the forecast period, driven by rising demand for effective implants and membranes for dental restoration as a result of rising oral health concerns. Manufacturers are concentrating on producing new and highly efficient implant and restoration products in order to meet rising demand. In February 2019, Zimmer Biomet Holdings, a worldwide healthcare corporation, announced the addition of non-resorbable membranes and sutures to its dental product portfolio.
The Impact of Coronavirus on the Dental Membrane and Bone Graft Substitutes Market in the United States (COVID-19) Pandemic
During the forecast period, the COVID-19 pandemic is likely to stymie the expansion of the dental membrane and bone graft replacements market in the United States. Up until September 23, 2021, about 43 million cases and 0.69 million deaths due to coronavirus (COVID-19) were reported in the United States, according to the World Health Organization's Coronavirus Disease (COVID-19) Weekly Epidemiological Update.
Players to Watch
Institut Straumann AG, Nobel Biocare Services AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., BioHorizons, Inc., NovaBone Products, LLC, Collagen Matrix, Inc., Maxigen Biotech, Inc., Osteogenics Biomedical, Medtronic, and OUSIA are among the major players in the dental membrane and bone graft substitutes market in the United States.
0 Comments